Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Insa Sommer"'
Autor:
Florian Methling, Steffen A. Borden, Deepak Veeraraghavan, Insa Sommer, Johannes Ulrich Siebert, Rüdiger von Nitzsch, Mark Seidler
Publikováno v:
Decision Analysis. 19:337-353
Pharmaceutical companies have frequent portfolio reviews to monitor development progress and prioritize development assets. The earliest assets are drug candidates whose efficacy is unknown and whose effects on the human body have yet to be fully inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5cbad1d61cffb26f0471534ebcb300d
https://doi.org/10.1287/deca.2022.0452
https://doi.org/10.1287/deca.2022.0452
